Logo



DLHAX - Delaware Healthcare A

Don't let mutual funds siphon away your returns.
Get our FREE Report: "Index Funds and ETFs – A Smarter Way To Invest"
Your Mutual Fund

Delaware Healthcare A (DLHAX)
Expense Ratio: 1.60%
Expected Lifetime Fees: $44,785.40


The Delaware Healthcare A fund (DLHAX) is a Health fund started on 09/28/2007 and has $51.50 million in assets under management. The current manager has been running Delaware Healthcare A since 10/19/2007. The fund is rated by Morningstar. In addition to trading fees and broker commissions, this fund has 12b-1 fees of 0.25%

MarketRiders Prefers The Following ETF

Vanguard Health Care ETF (VHT)
Expense Ratio: 0.19%
Expected Lifetime Fees: $6,157.84


The Vanguard Health Care ETF (VHT) is an Exchange Traded Fund. It is a "basket" of securities that index the Health investment strategy and is an alternative to a Health mutual fund. Fees are very low compared to a comparable mutual fund like Delaware Healthcare A because computers automatically manage the stocks.




The Following Health Funds Have Lower Fees Than Delaware Healthcare A (DLHAX). Why are these metrics important?
Mutual Fund Name Ticker Symbol Turnover Assets (M) Annual Fees
Alger Health Sciences A AHSAX 63.2% 191 1.35%
Allianz RCM Wellness A RAGTZ 127.0% 121 1.46%
Allianz RCM Wellness D DGHCX 127.0% 121 1.46%
BlackRock Health Sciences Opps Inst SHSSX 135.0% 1,700 1.01%
BlackRock Health Sciences Opps Inv A SHSAX 135.0% 1,700 1.32%
BlackRock Health Sciences Opps Svc SHISX 135.0% 1,700 1.33%
DWS Health Care A SUHAX 21.0% 174 1.55%
DWS Health Care S SCH1Z 21.0% 174 1.25%
DWS Health Care S SCHLX 21.0% 174 1.25%
Eaton Vance Worldwide Health Sciences Fund Class I EIHSX 43.0% 961 1.55%
Fidelity Advisor Biotechnology I FBTIX 99.0% 118 1.04%
Fidelity Advisor Health Care A FACDX 125.0% 464 1.19%
Fidelity Advisor Health Care I FHCIX 125.0% 464 0.89%
Fidelity Advisor Health Care T FACTX 125.0% 464 1.44%
Franklin Biotechnology Discovery A FBDIX 235.1% 429 1.32%
Franklin Biotechnology Discovery A FBT1Z 235.1% 429 1.32%
Hartford Healthcare A HGHAX 44.0% 406 1.49%
Hartford Healthcare I HGHIX 44.0% 406 1.18%
Hartford Healthcare R5 HGHTX 44.0% 406 1.05%
Janus Global Life Sciences Fund Class A JFNAX 54.0% 739 1.05%
Janus Global Life Sciences Fund Class I JFNIX 54.0% 739 0.85%
Janus Global Life Sciences Fund Class S JFNSX 54.0% 739 1.22%
Janus Global Life Sciences T JAGLX 54.0% 739 0.98%
Manning & Napier Life Sciences EXLSX 84.0% 217 1.12%
Prudential Jennison Health Sciences A PHLAX 54.0% 1,100 1.25%
Prudential Jennison Health Sciences L JSI1Z 54.0% 1,100 1.45%
Prudential Jennison Health Sciences Z PHSZX 54.0% 1,100 0.95%
Putnam Global Health Care A PHSTX 35.0% 928 1.26%
Putnam Global Health Care Y PHSYX 35.0% 928 1.01%
Rydex Biotechnology Inv RYOIX 333.0% 163 1.39%
Schwab Health Care SWHFX 24.0% 440 0.82%
T. Rowe Price Health Sciences PRHSX 23.3% 4,100 0.82%
Vanguard Health Care Adm VGHAX 8.0% 21,500 0.30%
Vanguard Health Care Inv VGHCX 8.0% 21,500 0.35%



Search for a mutual fund by symbol or name:

x
Why Are These Metrics Important?


Turnover
Turnover represents how much of a mutual fund's holdings are changed over the course of a year through buying and selling. Active mutual funds have an average turnover rate of about 85%, meaning that funds are turning over nearly all of their holdings every year. A high turnover means you could make lower returns because: 1) buying and selling stocks costs money through commissions and spreads and 2) the fund will distribute yearly capital gains which increases your taxes. Look for funds with turnover rates below 50%. For comparison, ETF turnover rates average around 10% or lower.

Assets
Generally, smaller funds do better than larger ones. The more assets in a mutual fund, the lower the chance that it will beat its index. Managers outperform an index by choosing stocks that are undervalued. In order to find these undervalued stocks, the manager has to know more than his competitors to develop an "edge." There are only a finite number of stocks a mutual fund manager can reasonably analyze and actively track to gain such a competitive edge. When the fund has more assets, the manager must analyze large companies because he needs to take larger positions. Large companies are more efficiently priced in the market and it becomes increasingly difficult to get an edge.